Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med.Sci. (Basel) 8(1), 15 (2020). • Updated data.
  CASGoogle Scholar
• 2. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115(1), 68–74 (2009).
  Google Scholar
• 3. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA 306(7), 737–745 (2011).
  CASGoogle Scholar
• 4. Tarantino G, Crocetto F, Di Vito C et al. Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study. J. Clin. Med. 10(2), 346 (2021). • Novel research.
  CASGoogle Scholar
• 5. Burger M, Catto JW, Dalbagni G et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63(2), 234–241 (2013).
  Google Scholar
• 6. Alifrangis C, McGovern U, Freeman A, Powles T, Linch M. Molecular and histopathology directed therapy for advanced bladder cancer. Nat. Rev. Urol. 16(8), 465–483 (2019).
  CASGoogle Scholar
• 7. Pfannstiel C, Strissel PL, Chiappinelli KB et al. The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer Immunol. Res. 7(6), 923–938 (2019).
  CASGoogle Scholar
• 8. Yuksel OH, Akan S, Urkmez A, Yildirim C, Sahin A, Verit A. Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence. Mol. Clin. Oncol. 5(1), 201–206 (2016).
  CASGoogle Scholar
• 9. DeGeorge KC, Holt HR, Hodges SC. Bladder cancer: diagnosis and treatment. Am. Fam. Physician 96(8), 507–514 (2017).
  Google Scholar
• 10. Bada M, De Concilio B, Crocetto F et al. Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single-center experience with 10-year outcomes. Minerva Urol. Nefrol. 72(5), 641–643 (2020).
  Google Scholar
• 11. Yin M, Joshi M, Meijer RP et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist 21(6), 708–715 (2016).
  CASGoogle Scholar
• 12. Sherif A, Holmberg L, Rintala E et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur. Urol. 45(3), 297–303 (2004). •• Basic clinical investigation.
  CASGoogle Scholar
• 13. Advanced bladder cancer (ABC) meta-analysis collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur. Urol. 48(2), 202–205; discussion 205–206 (2005). • Interesting research.
  Google Scholar
• 14. Rosenblatt R, Sherif A, Rintala E et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer. Eur. Urol. 61(6), 1229–1238 (2012).
  Google Scholar
• 15. Witjes JA, Bruins HM, Cathomas R et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur. Urol. 79(1), 82–104 (2021). • Updated data.
  CASGoogle Scholar
• 16. DeSantis CE, Lin CC, Mariotto AB et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 64(4), 252–271 (2014).
  Google Scholar
• 17. Peng D, Zhang C-J, Gong Y-Q et al. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Sci. Rep. 8(1), 1–9 (2018).
  Google Scholar
• 18. Zhang L, Li L, Liu J et al. Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer. Medicine 99(30), e20920 (2020).
  CASGoogle Scholar
• 19. Black AJ, Zargar H, Zargar-Shoshtari K et al. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. In: Urologic Oncology: Seminars and Original Investigations. Elsevier, 3.e17–13.e27 (2020). • Novel research.
  Google Scholar
• 20. Kaiser J, Li H, North SA et al. The prognostic role of the change in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a retrospective, multi-institutional study. Bladder Cancer 4(2), 185–194 (2018).
  Google Scholar
• 21. Peng Y, Xue Y, Wang J et al. Association between neutrophil-to-albumin ratio and mortality in patients with cardiogenic shock: a retrospective cohort study. BMJ Open 10(10), e039860 (2020).
  Google Scholar
• 22. Tingle SJ, Severs GR, Goodfellow M, Moir JA, White SA. NARCA: a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. J. Surg. Oncol. 118(4), 680–686 (2018).
  CASGoogle Scholar
• 23. Li R, Sun Z, Song S et al. NARFIB: a novel prognostic score based on the neutrophil-to-albumin ratio and fibrinogen can predict the prognosis of gastrointestinal stromal tumors. Cancer Manag. Res. 12, 11183–11190 (2020).
  CASGoogle Scholar
• 24. Tawfik B, Mokdad AA, Patel PM, Li HC, Huerta S. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation. Anticancer Drugs 27(9), 879–883 (2016).
  CASGoogle Scholar
• 25. Gong Y, Li D, Cheng B, Ying B, Wang B. Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiol. Infect. 148, e87–e87 (2020).
  CASGoogle Scholar
• 26. Cui H, Ding X, Li W, Chen H, Li H. The neutrophil percentage to albumin ratio as a new predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction. Med. Sci. Monit. 25, 7845–7852 (2019).
  CASGoogle Scholar
• 27. Sun T, Shen H, Guo Q et al. Association between neutrophil percentage-to-albumin ratio and all-cause mortality in critically ill patients with coronary artery disease. Biomed. Res. Int. 2020, 8137576 (2020). • Interesting clinical investigation.
  Google Scholar
• 28. Wang B, Li D, Cheng B, Ying B, Gong Y. The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute kidney injury. Biomed. Res. Int. 2020, 5687672 (2020).
  Google Scholar
• 29. Vartolomei MD, Ferro M, Cantiello F et al. Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non-muscle-invasive bladder cancer. Clin. Genitourin. Cancer 16(6), 445–452 (2018). •• Interesting clinical investigation.
  Google Scholar